(Q39481202)

12 September 2017

title

PPP2R1A mutations are common in the serous type of endometrial cancer (English)

1 reference

12 September 2017

0 references

Deepak C Nagendra

1

1 reference

12 September 2017

James Burke

series ordinal

2

1 reference

12 September 2017

G Larry Maxwell

series ordinal

3

1 reference

12 September 2017

John I Risinger

series ordinal

4

1 reference

12 September 2017

publication date

31 August 2011

1 reference

12 September 2017

published in

Molecular Carcinogenesis

1 reference

12 September 2017

volume

51

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

826-831

1 reference

describes a project that uses

12 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Molecular basis of endometrial cancer

1 reference

Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma

21 January 2018

1 reference

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer

21 January 2018

1 reference

Mutations of the Ki-ras oncogene in endometrial carcinoma

21 January 2018

1 reference

Mutations of the beta-catenin gene in endometrial carcinomas.

21 January 2018

1 reference

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 January 2018

1 reference

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

21 January 2018

1 reference

p53 gene mutations in human endometrial carcinoma

21 January 2018

1 reference

p53 overexpression in advanced-stage endometrial adenocarcinoma

21 January 2018

1 reference

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

21 January 2018

1 reference

Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium.

21 January 2018

1 reference

FGFR2 mutations are rare across histologic subtypes of ovarian cancer

21 January 2018

1 reference

Somatic mutations of PPP2R1A in ovarian and uterine carcinomas

21 January 2018

1 reference

Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas

21 January 2018

1 reference

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

21 January 2018

1 reference

Serine/threonine phosphatases: mechanism through structure

21 January 2018

1 reference

PP2A: unveiling a reluctant tumor suppressor

21 January 2018

1 reference

The role of PP2A A subunits in tumor suppression

21 January 2018

1 reference

The 3D structure of protein phosphatase 2A: new insights into a ubiquitous regulator of cell signaling

21 January 2018

1 reference

Structural Basis of PP2A Inhibition by Small t Antigen

21 January 2018

1 reference

Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme

21 January 2018

1 reference

Structure of the protein phosphatase 2A holoenzyme

21 January 2018

1 reference

Multiple pathways regulated by the tumor suppressor PP2A in transformation

21 January 2018

1 reference

A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins

21 January 2018

1 reference

Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma

21 January 2018

1 reference

Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.20850

1 reference

release_33pvkseo2rgrpfhbbez6eqzp4e

12 September 2017

Fatcat ID

0 references

1 reference